HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Primary myelofibrosis successfully treated with allogeneic bone marrow transplantation].

Abstract
A 31-year-old man with primary myelofibrosis initially received low dose Ara C. Splenomegaly decreased but pancytopenia continued. Allogeneic bone marrow transplantation from his sister was then performed. Busulfan and cyclophosphamide were used as a preconditioning regimen, which included neither irradiation nor splenectomy. As the bone marrow was hypoplastic after transplantation, G-CSF was given. It was useful for systemic infection. After transplantation, leukoerythroblastosis and tear drop poikilocytosis disappeared in peripheral blood. Finally, bone marrow fibrosis disappeared and hemopoiesis to normal limits recovered 17 months later. These results demonstrate that bone marrow transplantation is effective for primary myelofibrosis for which there is no otherwise curative therapy.
AuthorsN Iwata, N Inoue, A Tamura, E Miyazaki, Y Fujimori, T Okamoto, Y Takemoto, M Kosaki, A Kanamaru, E Kakishita
Journal[Rinsho ketsueki] The Japanese journal of clinical hematology (Rinsho Ketsueki) Vol. 33 Issue 11 Pg. 1703-7 (Nov 1992) ISSN: 0485-1439 [Print] Japan
PMID1469787 (Publication Type: Case Reports, English Abstract, Journal Article)
Topics
  • Adult
  • Bone Marrow Transplantation
  • Humans
  • Male
  • Primary Myelofibrosis (pathology, surgery)
  • Remission Induction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: